Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin-2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

Figure 3

Comparison of the CCL24 (eotaxin-2) mRNA expression in bilateral eyes of a vernal keratoconjunctivitis (VKC) patient. A 10-year-old boy had VKC, showing laterality in the severity of the objective findings. The levels of CCL24 (eotaxin-2) mRNA expression on the ocular surface were low (17.2) in the left eye with mild VKC and high (203.2) in the right eye with severe VKC.